Local, State & Federal Advocacy. Module 4 Discussion.

Local, State & Federal Advocacy

What are specific actions that health professionals can take regardless of their practice area and site to promote population and community health?
What advocacy actions might you take to improve health care through legislation at the state or federal level?

Submission Instructions:
Your initial post should be at least 500 words, formatted and cited in current APA style with support from at least 2 academic sources.

Discussion Question:

What is the role of theory in research and how is theory useful in research? How does theory guide policy? Discuss the steps in how to “Do” theoretical research? Lastly, what does criminological and criminal justice research seek to explain? (See Cochran & Mears, 2019).

Information System Management

Suppose you are the IT manager for an IT company. You receive a report that contains a list of computer equipment stored in the company warehouse. You notice that the list also includes items that you know are not stored in the warehouse. Would you consider this list as good information? Why, or why not? Give some examples of at least three items on this list that you consider to be good information and at least three items on this list that would not be good information. Explain your reasoning and include a discussion about why good information is important in MIS.


Post an explanation of the costs and benefits of personality tests compared to other quantitative predictors that a personnel consultant may have considered using in the employment context. Explain two potential consequences of faking a personality test. Finally, explain whether or not you consider faking personality tests to be a serious problem and why.

Human Resource Management

This week, you watched a video called “Leaders with values.” Using this video as your



• Choose one of the leaders from the “Leaders with values” video.

• Include the following in your

Describe the leadership obstacles this person faced.

Describe the actions or behaviors that he/she did that showed leadership

attributes. What showed that this person was a leader?

Explain what stood out to you that made you choose this individual?


• Develop a clear introduction with a thesis, a body, and a conclusion. Focus on

quality of writing, as opposed to length.

• Research and include at least one additional, credible reference from an outside

source pertaining to the leader you chose.

• Use APA formatting for the cover page, citations, and the reference page. No

abstract is required

Discussion Question

offer additional suggestions. Be sure they are informed by social psychology theory and research.


Before coming to Walden I completed an MBA program that was online. Every class in my two year program required group projects. Many times there were social loafers. The final class of my program was a capstone project that required creating a business. This was the worst time to have a social loafer (in hindsight it may have also been the best because the finish line was in sight). Everyone in our group of six took a different role in creating our mobile salon business. Everyone started with eager and enthusiasm. Each week we noticed one of our peers doing less and less. We had scheduled conference calls twice per week, sometimes three times depending on the workload. We noticed that he was absent more frequently. We nominated a CEO and requested that person contact the offender directly. The behavior did not change and the rest of us picked up his slack to ensure our grades were not impacted. Ultimately, we had to let the professor now that he was not contributing. This was probably not a surprise because we were also completing survey’s in which we graded our team members on their performance that week.

Reflecting on this experience causes me to think that our group handled this loafer well. It is certainly aligned with business expectations: confront the offender first and if that does not work then call HR. In our case the professor was HR. After reading Chapter 9, I am not surprised that his performance progressively worsened because arousal enhances performance on simple tasks but impairs performance on more complex tasks (Jackson & Williams, 1985). At the onset of class the assignments were easier than toward the end of class, where they became more complex. One strategy that we did not try was confronting his behavior during the calls. Specifically when discussing the surveys. We would often tell one another how we would rate the others when the rating was high. We did not discuss low ratings in a group setting. That may have been a reminder and motivator for him to contribute


PSY 108 Project Two Milestone: Journal Entry Key Takeaways

According to the speaker, how does procrastination work?How does the speaker suggest addressing procrastination?Connections

In what ways is procrastination a negative form of coping?In what ways is procrastination a positive form of coping?How might being intrinsically or extrinsically motivated relate to procrastination?Resilience When might procrastination be considered a good thing?According to the speaker, how can our inner “rational decision maker” and “instant gratification seeker” coexist?How do you think we can reframe procrastination in a more adaptive way to promote resilience?


DNP-810A Peers’ Posts Needing Responses

Abiodun Kolawole

Posted Date

The news story chosen for analysis is entitled “Dwarfism drug aims to boost healthy growth.” According to the article, achondroplasia is one of the most common types of dwarfism, which affects one individual in every 25,000 people (Roberts, 2019). Achondroplasia is a genetic disorder caused by the mutation of a gene that limits the growth of bones in the skull base, the limbs, and the spine (Pauli, 2019). The author describes the typical case of an achondroplasia-affected child named Sam with short legs and arms. However, researchers have developed a new type of medication known as vosoritide that promotes healthy growth among children born with dwarfism. The drug’s effectiveness can be proven by comparing the growth of Sam before and after the injection before he joined the study. Sam grew 3cm (1in) after the injection and another 6cm in the first year after treatment (Roberts, 2019). In terms of ethics, RNs or APRNs are concerned about whether the drug can prevent growth-related complications. In terms of societal implications, the approval of the medication would change dwarfism. However, there is still uncertainty about whether individuals with the disorder would support the intervention. Because vosoritide has not yet gained FDA approval, RNs and APRNs cannot prescribe the drug to their patients at this time. Culture can influence how disability is understood and how individuals with disabilities are treated. As a result of media narratives that inaccurately portray disability, societal beliefs become dominant (Haller, 2010). However, the effect of these beliefs on dwarfs in the community has been largely ignored. Dwarfs are often subjected to unwanted attention due to their appearance, including staring and verbal abuse, which can be considered a social disability.


Haller, B.A. (2010) Representing Disability in an Abelist World. Louisville: The Avocado Press.

Roberts, M. (2019). Dwarfism drug aims to boost healthy growth. Retrieved May 12, 2022, from https://www.ncbi.nlm.nih.gov/search/research-news/3265/

Pauli RM. Achondroplasia: a comprehensive clinical review. Orphanet J Rare Dis. 2019 Jan 3;14(1):1. https:// doi.org/ 10.1186/s13023-018-0972-6.

Solomon, S. (2020) Dwarf Pride’ Was Hard Won. Will a Growth Drug Undermine It. Retrieved May 12, 2022, from https://www.ncbi.nlm.nih.gov/search/research-news/11271/

Kristen Williams

Ribonucleic acid (RNA) plays an essential role in messenger Ribonucleic acid (mRNA) translating and decoding (D’Ascenzo et al., 2022). Advancements in technology have improved scientists’ ability to sequence RNA leading to the development of medication and targeted therapies. Advances in RNA sequences have led to biotech companies’ billions in investments (Wang et al., 2020). The potential impact on the pharmaceutical industry from targeted drug development is massive and has the potential to save millions of lives. Although the potential to save lives is vast many ethical, fiscal, and social issues arise. Many uncertainness surrounds the role of genomics in the prognosis and management of diseases (Newson et al., 2016).

The advancements in RNA have led to more advanced medication development. Although improvements are taking place in the effect of medications, access continues to be a problem. Prescription medicines are not assessable to many due to financial causes. Social and ethical dilemmas currently reside around increasing access to medication as this technology advances. As billions are poured into developing new medicines and treatments, society needs to ensure they are accessible to those who need them. For developing technology to be accessible, a shift must occur in our culture surrounding healthcare. Currently, access to healthcare is a privilege and not a right. There is potential that as technology advances, a cultural shift will occur, and healthcare will be viewed as a right and expanded to those in need.


D’Ascenzo, L., Popova, A. M., Abernathy, S., Sheng, K., Limbach, P. A., & Williamson, J. R. (2022). Pytheas: A software package for the automated analysis of RNA sequences and modifications via tandem mass spectrometry. Nature Communications, 13(1). https://doi.org/10.1038/s41467-022-30057-5

Newson, A. J., Leonard, S. J., Hall, A., & Gaff, C. L. (2016). Known unknowns: Building an ethics of uncertainty into genomic medicine. BMC Medical Genomics, 9(1). https://doi.org/10.1186/s12920-016-0219-0

Wang, F., Zuroske, T., & Watts, J. K. (2020). Rna therapeutics on the rise. Nature Reviews Drug Discovery, 19(7), 441–442. https://doi.org/10.1038/d41573-020-00078-0

Yu, A.-M., Choi, Y., & Tu, M.-J. (2020). Rna drugs and RNA targets for small molecules: Principles, progress, and challenges. Pharmacological Reviews, 72(4), 862–898. https://doi.org/10.1124/pr.120.019554


In Module two, you were asked to describe an issue ADVOCACY FOR NURSING SHORTAGE and you hoped to improve and you created a presentation about the plan. This week, you will present on the progress and results you have made during the past 5 weeks.

Your policy change proposal could have been with state Board of nursing, local boards, state representatives, or members of Congress/Senate. Based on the issues you selected in Module two, that you were passionate about, researched in depth, and contacted the appropriate policy maker (preferably in person, but at least by emails or letters) – detail your position and the evidence that supports it, and explain your results, determination and outcomes for the contact with policy makers in a 20 slide PowerPoint presentation with audio and speaker notes on all content slides. Make certain to include your sources and a reference slide.

Skin Assessment

Conduct an assessment on the following body system:

You may conduct the assessment on a fellow student, friend, or family member. Remember to secure their permission.

Collect both subjective and objective data using the process described in the textbook.

Write a summary of the assessment and the skills utilized. Answer the following 3 questions in the summary. Do not disclose any patient identifiers.

What skills (assessment techniques) were utilized during the assessment?
What subjective data did you collect? (list your findings)
What objective data did you collect? (list your findings
Then, document your subjective & Objective findings on a WORD document. APA format isn’t required.